Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc. Ushering in a new era for treating diseases with high unmet needs

09/03/2026

Amylyx was founded with the intention of making a major impact on humanity.

If you want to focus your career on helping people who live with devastating diseases, this is an incredible time to join our team.

If you have passion to help others, we can’t wait to meet you. Apply here: https://bit.ly/4cXgmVo

is in Toronto this week for the International Federation for the Surgery and Other Therapies for Obesity’s XXIX IFSO W...
09/01/2026

is in Toronto this week for the International Federation for the Surgery and Other Therapies for Obesity’s XXIX IFSO World Congress. If you’re in attendance, we look forward to connecting with you!

08/26/2026

Every breakthrough starts with people like Amy Shabazz who are passionate about helping others and engaged in the work they do. At Amylyx, you'll join teams united by a shared mission and empowered to make a meaningful impact every day.

If you're ready to work besides a talented, thoughtful group of people who are determined to make a difference, we'd like to meet you.

Explore career opportunities: https://bit.ly/4zGBngU

We’re excited to share positive topline results from the pivotal Phase 3 LUCIDITY clinical trial of our investigational ...
08/18/2026

We’re excited to share positive topline results from the pivotal Phase 3 LUCIDITY clinical trial of our investigational GLP-1 receptor antagonist in post-bariatric hypoglycemia (PBH).

Read more: https://bit.ly/Phase3Lucidity

We are deeply grateful to everyone who has made LUCIDITY possible. Based on these results, we plan to submit a New Drug Application (NDA) by year-end.

08/14/2026

At Amylyx, we’re Rooted in Connection. We partner with community members, caregivers, healthcare providers, and advocates to listen, learn, and act on what matters most.

These insights help shape our approach to education, advocacy, and advancing research, because meaningful progress starts with understanding the lived experiences of the people we serve. Learn more: https://bit.ly/4x5RUJy

The work we do at Amylyx isn't easy, but it's always meaningful. Every day, our teams come together with a shared sense ...
08/11/2026

The work we do at Amylyx isn't easy, but it's always meaningful. Every day, our teams come together with a shared sense of purpose: to solve complex challenges, create lasting impact, and improve the lives of the people and communities who depend on us.

It’s employees like Tammy Sarnelli who believe in what's possible and continue to drive our mission forward.

08/06/2026

Wolfram syndrome is a rare, monogenic neurodegenerative disorder that progressively impacts multiple organs and systems.

Most people with Wolfram syndrome carry mutations in the WFS1 gene, which produces a protein called wolframin that spans the membrane of the endoplasmic reticulum (ER). Loss of wolframin function can lead to ER stress and impaired mitochondrial dynamics. Learn more about Wolfram syndrome on our website at
https://bit.ly/4z3mftF

Culture isn't defined by what we say — it's defined by the decisions we make. At Amylyx, putting communities first is mo...
08/04/2026

Culture isn't defined by what we say — it's defined by the decisions we make. At Amylyx, putting communities first is more than a guiding principle; it's how we approach challenges, drive innovation, and support one another every day. That commitment is what attracts exceptional people, like David Heisch, and inspires them to do their best work for the people who inspire and rely on them.

07/30/2026

Building on our efforts to advance awareness of post-bariatric hypoglycemia (PBH), we've launched a new community website for individuals in the U.S. living with or affected by PBH. This resource provides educational information to help people better understand the condition and encourage them to engage in conversations with their healthcare team. This site is available at UncoverPBH.com.

07/28/2026

Meet the people and purpose behind . In this video, Amylyx co-founders and co-CEOs Josh Cohen and Justin Klee share their perspectives on our mission, values, and the responsibility to communities with high unmet needs that guides our work every day.

Learn more about our culture and explore opportunities to join our audacious team: https://bit.ly/3TrmBtN

Address

55 Cambridge Parkway, Suite 6W
Cambridge, MA
02142

Website

, ,

Alerts

Be the first to know and let us send you an email when Amylyx Pharmaceuticals Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share